Safety and Tolerability of GX-P1 in Healthy Male Volunteers

Status:
Completed

Trial end date:
2021-06-07

Target enrollment:

Participant gender:

This study is a single-center, double-blind, placebo-controlled, phase I study with healthy male volunteers receiving ascending single dose of GX-P1

Phase 1

Genexine, Inc.